Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2).

Human molecular genetics - 15 Feb 2014

Tanaka Yoshiaki, Kim Kun-Yong, Zhong Mei, Pan Xinghua, Weissman Sherman Morton, Park In-Hyun

Abstract excerpt

Rett syndrome (RTT) is one of the most prevalent female mental disorders. De novo mutations in methyl CpG-binding protein 2 (MeCP2) are a major cause of RTT. MeCP2 regulates gene expression as a transcription regulator as well as through long-range chromatin interaction. Because MeCP2 is present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Embryonic Stem Cells
Share to Gene Expression Regulation
Share to Gene Ontology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Methyl-CpG-Binding Protein 2

Share to Rett Syndrome

Share to Transcription, Genetic

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 24129406
DOI: 10.1093/hmg/ddt500
PMCID: PMC3900111

Genes

MECP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24129406-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2).PMID 24129406Read ↗

MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies.Semantic proximity Read ↗

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.Semantic proximity Read ↗

Rett syndrome and MeCP2.Semantic proximity Read ↗

Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.Semantic proximity Read ↗

Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders.Semantic proximity Read ↗

MECP2 mutations disrupt pluripotent stem cell fate through remodeling of the three-dimensional genome.Semantic proximity Read ↗

Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.Semantic proximity Read ↗

Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development.Semantic proximity Read ↗

Rett syndrome: insights into genetic, molecular and circuit mechanisms.Semantic proximity Read ↗

The molecular pathology of Rett syndrome: synopsis and update.Semantic proximity Read ↗

Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.Semantic proximity Read ↗

Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.